GPP
SANA icon

Great Point Partners’s Sana Biotechnology SANA Stock Holding History

Great Point Partners’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-700,000
Closed -$2.85M – 48
2025
Q4 		$2.85M Hold
700,000
– – 0.92% 26
2025
Q3 		$2.48M Buy
+700,000
New +$2.53M 1.02% 26

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Great Point Partners's SANA Position: Q1 2026 in Review

Great Point Partners sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 700,000 shares — an estimated $2.85M sold.

Great Point Partners first reported a position in SANA in Q3 2025 and held it in 2 quarters. The position peaked at $2.85M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Great Point Partners reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Great Point Partners sold 700,000 Sana Biotechnology shares in Q1 2026, an estimated $2.85M.
  • Great Point Partners first reported a position in Sana Biotechnology in Q3 2025 and held it in 2 quarters.
  • Great Point Partners's Sana Biotechnology position peaked at $2.85M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Great Point Partners's 13F filing for Q1 2026, filed 15 May 2026.